Perioperative Pembrolizumab Wins Canadian Approval for Resectable NSCLC
Health Canada has approved perioperative pembrolizumab for resectable non–small cell lung cancer.
Related Articles
Clinical Trials Underestimate HRQOL Burden on R/R Myeloma Population
A retrospective systemic literature review showed that increased lines of therapy led to decreased HRQOL in patients with relapsed/refractory myeloma.
A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer
Acha-Sagredo et al. stratify colorectal cancers using features of an immune-reactive tumor microenvironment. This microenvironment, locally abundant in cytotoxic lymphocytes and antigen-presenting macrophages, facilitates immunotherapy response…
SABR Conference – Stereotactic Ablative Radiotherapy Canada
Please join us at the SABR Canada Conference taking place on Thursday June 5 & Friday June 6, 2025, at the Delta by Marriott Grand…
Virtual Tumor Board: Treating EGFR NSCLC After TKI Resistance | IASLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This…
Volume 9 Issue 3 | Blood Advances | American Society of Hematology
Blood Advances | 9 | 3 | February 2025
Anesthetic Considerations for Gynecologic High Dose Rate Brachytherapy
High dose rate (HDR) brachytherapy is an essential component in the curative treatment for many gynecologic (gyn) cancers, including cervical cancer, uterine cancer, vaginal cancer,…
World Cancer Day 2025: A symbol of personal and collective uncertainty – The Cancer Letter
My entire life I was told to respectfully question anything and everything, because questions equal answers, which provide understanding and thereby comfort—even with the uncomfortable.…
Nurse-Led Counseling, Care Reduced Complications Following Gastric Cancer Surgery – Oncology Nurse Advisor
In a comparison study, benefits of nurse-led preoperative counseling and follow-up care was significantly greater compared with surgeon-led or no counseling models.
Serial CTRS Receives FDA Breakthrough Device Designation for NSCLC Prognosis
Serial CTRS, an AI-powered tool, has been granted FDA breakthrough device designation for classifying patients with NSCLC.
How to Choose Effective SEO Keywords for Your Research Article | How to Write a Journal Article
Find 5 helpful tips about using keywords in your research article to help journals, and your article, be found more easily by researchers.
